Anaphylaxis: Current state of knowledge for the modern physician

Postgraduate Medical Journal

Volumn 88, Issue 1042, 2012, Pages 458-464

  Rutkowski, Krzysztof ^a   Dua, Shelley ^a   Nasser, Shuaib ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORPHENIRAMINE; HISTAMINE; HYDROCORTISONE; IMMUNOGLOBULIN E; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RANITIDINE; SALBUTAMOL; TRYPTASE;

ANAPHYLAXIS; ANESTHESIA; ANGIONEUROTIC EDEMA; BRADYCARDIA; CELL ACTIVATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; EDUCATION; EXERCISE; FOOD ALLERGY; HEART; HUMAN; HYPOTENSION; INSECT ALLERGY; MAST CELL; MUCOSA; OXYGEN THERAPY; PATHOGENESIS; PRACTICE GUIDELINE; PREVALENCE; RED MEAT; REVIEW; SKIN; SYNCOPE; TACHYCARDIA; UNITED KINGDOM; URTICARIA;

ALLERGENS; ANAPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; EPINEPHRINE; FOOD; HUMANS; INJECTIONS, INTRAMUSCULAR; INSECT BITES AND STINGS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; TIME FACTORS; TRYPTASES;

EID: 84864098070     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2011-130634     Document Type: Review

References (66)

1. National Institute for Health and Clinical Excellence. NICE Clinical Guideline 134. Anaphylaxis: Assessment to Confirm an Anaphylactic Episode and the Decision to Refer After Emergency Treatment for a Suspected Anaphylactic Episode. 2011:1-95.
2. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report e Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 2006;117:391-7.
3. Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006;97:596-602.
4. Gupta R, Sheikh A, Strachan DP, et al. Time trends in allergic disorders in the UK. Thorax 2007;62:91-6.
5. Poulos LM, Waters AM, Correll PK, et al. Trends in hospitalisations for anaphylaxis, angioedema and urticaria in Australia 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007;120:878-84.
6. Shen Y, Li L, Grant J, et al. Anaphylactic deaths in Maryland (US) and Shanghai: a review of forensic autopsy cases from 2004-2006. Forensic Sci Int 2009;186:1-5
7. Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009;123:434-42.
8. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30:1144-50.
9. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002;110:341-8.
10. Schmidt-Traub S, Bamler KJ. The psychoimmunological association of panic disorder and allergic reaction. Br J Clin Psychol 1997;36:51-62.
11. Dewachter P, Mouton-Faivre C, Emala CW. Anaphylaxis and anaesthesia: controversies and new insights. Anesthesiology 2009;111:1141-50.
12. Simons FE, Ardusso LR, Bilo MB, et al; World Allergy Organization. World Allergy Organisation guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol 2011;127:587-93
13. Khan BQ, Kemp SF. Pathophysiology of anaphylaxis. Curr Opin Allergy Clin Immunol 2011;11:319-25.
14. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1988;14;17-21.
15. Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003;112:451-2.
16. Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005;60:443-51.
17. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191-3.
18. Summers CW, Pumphrey RS, Woods CN, et al. Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist centre. J Allergy Clin Immunol 2008;121:632-38
19. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004;4:205-90.
20. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: post mortem findings and associated co-morbid diseases. Ann Allergy Asthma Immunol 2007;98:252-7.
21. de Silva IL, Mehr SS, Tey D, et al. Paediatric anaphylaxis: a 5 year retrospective review. Allergy 2008;63:1071-6.
22. Furlong TJ, DeSimone J, Sicherer SH. Peanut and tree nut allergic reactions in restaurants and other food establishments. J Allergy Clin Immunol 2001;108:867-70.
23. Sicherer SH, Furlong TJ, Munoz-Furlong A, et al. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 2001;108:128-32.
24. Shek LP, Lee BW. Food allergy in Asia. Curr Opin Allergy Clin Immunol 2006;6:197-201.
25. Simons FE. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol 2009;124:625-36
26. Golden DB. Insect allergy and venom immunotherapy: a model and mystery. J Allergy Clin Immunol 2005;115:439-47.
27. Golden DB, Marsh DG, Kagey-Sobotka A, et al. Epidemiology of insect venom sensitivity. JAMA 1989;262:240-4.
28. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 Update. J Allergy Clin Immunol 2010;126:477-80
29. Baert F, Norman M, Vermeire S, et al. Influence of immunogenicity on the long term efficacy of infliximab in Crohn's disease. N Engl J Med 2003;348:601-8.
30. Ewan PW, Dugue P, Mirakian R, et al. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 2009;40:15-31.
31. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anaest Analg 2003;97:1381-95.
32. Moss J. Allergic to Anaesthetics. Anaesthesiology 2003;99:521-3.
33. Mertes P, Laxenaire MC. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002;19:240-62.
34. Robson-Ansley P, Du Toit G. Pathophysiology, diagnosis and management of exercise-induced anaphylaxis. Curr Opin Allergy Clin Immunol 2010;10:312-17.
35. Romano A, Di Fonso M, Giuffreda F, et al. Food-dependent exercise-induced anaphylaxis: clinical and laboratory findings in 54 subjects. Int Arch Allergy Immunol 2001;125:264-72.
36. Shadick NA, Liang MH, Partridge AJ, et al. The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol 1999;104:123-7.
37. Harada S, Horikawa T, Ashida M, et al. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food- dependent exercise-induced anaphylaxis. Br J Dermatol 2001;145:336-9.
38. Wade JP, Liang MH, Sheffer AL. Exercise-induced anaphylaxis: epidemiologic observations. Prog Clin Biol Res 1989;297:175-82.
39. Commins SP, Satinover SM, Hosen J, et al. Delayed anaphylaxis, angioedema or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-a-1,3-galactose. J Allergy Clin Immunol 2009;123:426-33.
40. Payne V, Kam P. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004;59:695-703.
41. Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emerg Med Australas 2004;16:120-4.
42. Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol 2006;117:1411-14.
43. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 2006;26:451-63.
44. Yunginger JW, Nelson DR, Squillance DL, et al. Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 1991;36:857-65.
45. Randall B, Butts J, Halsey JF. Elevated post-mortem tryptase in the absence of anaphylaxis. J Forensic Sci 1995;40:208-11.
46. Edston E, van Hage-Hamsten M. Mast cell tryptase and haemolysis after trauma. Forensic Sci Int 2003;131:8-13.
47. Simons FE. Anaphylaxis. J Allergy Clin Immunol 2008;121(2 Suppl):S402-20.
48. Schwartz HJ. Anaphylaxis: issues in diagnosis. Curr Opin Allergy Clin Immunol 2001;1:357-9.
49. Sanza ML, Gamboab PM, Garci{dotless}́a-Figueroac BE, et al. In vitro diagnosis of anaphylaxis. Chem Immunol Allergy 2010;95:125-40.
50. Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase and severe anaphylaxis. N Engl J Med 2008;358:28-35.
51. Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy 2011;41:923-38.
52. Simons FE. Anaphylaxis. J Allergy Clin Immunol 2009;125:S161-81.
53. Lee J, Kim S, Kim M, et al. Anaphylaxis to husband's seminal plasma and treatment by local desensitization. Clin Mol Allergy 2008;6:13-15
54. Simons FE. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 2006;117:367-77.
55. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-6.
56. Sheikh A, Shehata YA, Brown SG, et al. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy 2009;64:204-22.
57. Kajiwara N, Sasaki T, Bradding P, et al. Activation of human mast cell through the platelet-activating factor receptor. J Allergy Clin Immunol 2010;125:137-45.
58. Brown SG, Blackman KE, Stenlake V, et al. Insect sting anaphylaxis: prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004;21:149-54.
59. El-Shanawany T, Williams PE, Jolles S. Clinical immunology review series: an approach to the patients with anaphylaxis. Clin Exp Immunol 2008;153:1-9.
60. Resuscitation Council UK. Resuscitation Guidelines. 2010. http://www.resus.org.uk (accessed 19 Sep 2011).
61. Apostolou E, Deckert K, Puy R, et al. Anaphylaxis to gelofusine confirmed by in vitro basophil activation test: a case series. Anaesthesia 2006;61:264-8.
62. Gonzalez-Perez A, Aponte Z, Fernandez Vidaurre C, et al. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010;125:1098-104.
63. Tse Y, Rylance G. Emergency management of anaphylaxis in children and young people: new guidance from the Resuscitation Council (UK). Arch Dis Child Educ Pract Ed 2009;94:97-101.
64. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin North Am 2007;27:309-26.
65. Ewan PW, Clark AT. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet 2001;357:111-15.
66. Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 2005;115:575-83.